Indeed, preclinical and clinical studies have repeatedly demonstrated that an increase in the expression and activation of this inflammasome induces a higher release of cytokines, such as TNF-α, IL-1β, and IL-6, which have been shown to be elevated in individuals with this mood disorder. Here, IL1B is linked to mood disorder.